BA
ASTH icon

Bridgewater Associates’s Astrana Health ASTH Stock Holding History

Bridgewater Associates’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-16,424
Closed -$952K – 847
2024
Q3 		$952K Sell
16,424
-18,776
-53% -$923K 0.01% 608
2024
Q2 		$1.43M Sell
35,200
-3,720
-10% -$148K 0.01% 597
2024
Q1 		$1.63M Sell
38,920
-6,630
-15% -$259K 0.01% 522
2023
Q4 		$1.74M Sell
45,550
-1,963
-4% -$65.4K 0.01% 539
2023
Q3 		$1.47M Buy
47,513
+2,369
+5% +$81.7K 0.01% 551
2023
Q2 		$1.43M Sell
45,144
-5,129
-10% -$176K 0.01% 523
2023
Q1 		$1.83M Buy
50,273
+11,052
+28% +$387K 0.01% 472
2022
Q4 		$1.16M Sell
39,221
-10,291
-21% -$331K 0.01% 626
2022
Q3 		$1.93M Sell
49,512
-90
-0.2% -$4.12K 0.01% 573
2022
Q2 		$1.91M Buy
49,602
+6,454
+15% +$245K 0.01% 692
2022
Q1 		$2.09M Buy
43,148
+10,665
+33% +$550K 0.01% 675
2021
Q4 		$2.39M Sell
32,483
-16,041
-33% -$1.32M 0.01% 435
2021
Q3 		$4.42M Buy
48,524
+4,912
+11% +$418K 0.02% 306
2021
Q2 		$2.74M Buy
+43,612
New +$1.61M 0.02% 436

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bridgewater Associates's ASTH Position: Q4 2024 in Review

Bridgewater Associates sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 16,424 shares — an estimated $952K sold.

Bridgewater Associates first reported a position in ASTH in Q2 2021 and held it in 14 quarters. The position peaked at $4.42M in Q3 2021. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.

  • Bridgewater Associates reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
  • Bridgewater Associates sold 16,424 Astrana Health shares in Q4 2024, an estimated $952K.
  • Bridgewater Associates first reported a position in Astrana Health in Q2 2021 and held it in 14 quarters.
  • Bridgewater Associates's Astrana Health position peaked at $4.42M in Q3 2021.
  • 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.

Based on Bridgewater Associates's 13F filing for Q4 2024, filed 13 Feb 2025.